Landiolol: A Review in Tachyarrhythmias-Reference-Cited by-同舟云学术

Landiolol: A Review in Tachyarrhythmias

Published:2018-02-22 Issue:3 Volume:78 Page:377-388
ISSN:0012-6667
Container-title:Drugs
language:en
Short-container-title:Drugs

Author:

Syed Yahiya Y.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

http://link.springer.com/article/10.1007/s40265-018-0883-9/fulltext.html

Reference69 articles.

1. Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur J Heart Fail. 2016;18(8):891–975.

2. Kirchhof P, Benussi S, Kotecha D, et al. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016;37(38):2893–962.

3. Blomstrom-Lundqvist C, Scheinman MM, Aliot EM, et al. ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines and the European Society of Cardiology committee for practice guidelines (writing committee to develop guidelines for the management of patients with supraventricular arrhythmias) developed in collaboration with NASPE-Heart Rhythm Society. J Am Coll Cardiol. 2003;42(18):1493–531.

4. Rapibloc 20 mg/2 ml concentrate for solution for injection: summary of product characteristics. 2017. http://www.medicinesauthority.gov.mt . Accessed 21 Dec 2017.

5. Rapibloc 300 mg and 600 mg powder for solution for infusion: summary of product characteristics. 2017. https://mri.cts-mrp.eu . Accessed 24 Jan 2018.

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Landiolol for refractory ventricular fibrillation in out-of-hospital cardiac arrest: A randomized, double-blind, placebo-controlled, pilot trial;Resuscitation;2024-08

2. An Overview of the Pharmacokinetics and Pharmacodynamics of Landiolol (an Ultra-Short Acting β1 Selective Antagonist) in Atrial Fibrillation;Pharmaceutics;2024-04-08

3. Istaroxime for Patients with Acute Heart Failure: A Systematic Review and Meta-Analysis of Randomized Controlled Trials;Diseases;2023-12-17

4. Landiolol for the prevention of postoperative atrial fibrillation after cardiac surgery: a systematic review and meta-analysis;Canadian Journal of Anesthesia/Journal canadien d'anesthésie;2023-11

5. Efficacy and safety of intravenous beta-blockers in acute atrial fibrillation and flutter is dependent on beta-1 selectivity: a systematic review and meta-analysis of randomised trials;Clinical Research in Cardiology;2023-09-01